NCT00376896View on ClinicalTrials.gov

Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Irritable ColonIrritable Bowel Syndrome (IBS)
Interventions
DRUG

GW876008 200mcg

GW876008

DRUG

GW876008 20mcg

GW876008 20mcg

OTHER

Placebo

placebo

Trial Locations (1)

90095

GSK Investigational Site, Los Angeles

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY